ClinicalTrials.gg
Drug

Azacitidine clinical trials

Also written Vidaza, NSC-102816, Onureg and U-18496.

Includes 44 studies of Cc-486.

studies test it
441
open now
131
in phase 3
44
first study started
1999

How each study uses Azacitidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Azacitidine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 May 2004 · VIDAZA · NDA 050794 (FDA, Drugs@FDA)
European Union
17 Dec 2008 · Vidaza · EMEA/H/C/000978 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Azacitidine
252
5-azacytidine
45
Azacytidine
30
5-AZC
28
Ladakamycin
28

Brand

Vidaza
122
Onureg
3

Development codes

NSC-102816
20
U-18496
3
CC-486
1
NHT102
1

In one entry with another drug

Given together, or one or the other

CACAG+VEN
4
Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
3
Venetoclax, Azacitidine
2
azactidine
2

Studies by the year they started

437 studies that test it; most in 2026 (43); 4 more planned to start later

Studies that test Azacitidine, by start year
YearStudies
19991
20005
20031
200511
200613
20078
200815
200916
201024
201118
201215
201318
20148
201521
201612
201716
201819
201917
202020
202123
202229
202323
202432
202529
202643

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
160
Phase 2
280
Phase 3
44
Phase 4
7
No phase
21

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 74 · Other 367

M.D. Anderson Cancer Center (42) · National Cancer Institute (NCI) (29) · Celgene (28) · The First Affiliated Hospital of Soochow University (19) · Groupe Francophone des Myelodysplasies (10) · Institute of Hematology & Blood Diseases Hospital, China (10) · AbbVie (7) · Memorial Sloan Kettering Cancer Center (6)

Often tested with

Tested in the same studies.

Venetoclax (111) · Cytarabine (35) · Lenalidomide (21) · Decitabine (17) · Tucidinostat (14) · Gilteritinib (11) · Daunorubicin (10) · Ivosidenib (10)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Azacitidine is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 46, 5 in phase 3

Studies that test Azacitidine, phase 3 first.

Studies

Open first, then newest update. How each study uses Azacitidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 441

See all 441 studies that test Azacitidine →

Given beside what is tested · 261 — Azacitidine is usual care or a partner of the new treatment

Showing 20 of 261.

As the comparator · 13 — what is tested is compared with Azacitidine

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Azacitidine · ClinicalTrials.gg INT007036

  • MeSH (NLM) D001374AzacitidineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) M801H13NRUAZACITIDINEConfirmed FDA, NLM, Wikidata
  • RxNorm 1251Confirmed FDA, Wikidata
  • Wikidata Q416451azacitidineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C288AzacitidineOne source FDA
  • DrugBank DB00928One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.